
Chrysalis Capital is a pre-seed to growth stage investment firm based in Calgary, Canada. It has made 9 investments, with focus areas including Healthcare, Consumer, Education, Crypto & Web3, Fintech. 33% of their portfolio is in Healthcare. Average disclosed round size is $31.2M (across 8 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Series E
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series E | $47.1M | Mar 2024 | |
| Series E | $95M | May 2023 | |
| BBehaVR | Series B | $13M | Dec 2022 |
| Pre-Seed | $2M | Sep 2022 | |
| Growth | — | Jun 2022 | |
| Series A | $15M | Jan 2022 | |
| Seed | $2.5M | Apr 2021 | |
| SStraighterLine | Series A | $10M | Apr 2012 |
| Series C | $65M | — |
Top Co-Investors
Fidelity Investments2 shared
Launch Africa1 shared
Five351 shared
AngelList1 shared
New Markets Venture Partners1 shared
Optum Ventures1 shared
Oxford Science Enterprises1 shared
Accenture1 shared
FirstMark Capital1 shared
City Light Capital1 shared
RA Capital Management1 shared
Oak HC/FT1 shared
Nationwide1 shared
Kaiser Permanente Ventures1 shared
Lux Capital1 shared
Deerfield1 shared
Greycroft1 shared
Tiger Global Management1 shared
Y Combinator1 shared
Motley Fool Ventures1 shared
Last updated: 16 April 2026